AI assistant
Dr. Lal Pathlabs Limited — Call Transcript 2020
Mar 27, 2020
61783_rns_2020-03-27_18bc8b4f-43de-4e13-be33-a74378d71968.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [288 x 44] intentionally omitted <==
March 27, 2020
National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Sandra Kurla Complex Sandra (E) Mumbai - 400 051.
BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001
Dear Sir/Madam,
Sub: Intimation of Conference Call for Investors/Analysts to share Business Updates.
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015, please find attached the invite of the Conference Call for Investors/Analysts to be held on Monday, March 30, 2020 at 6:00 PM 1ST to share Business Updates.
You are requested to take note of the above.
Thanking You,
Yours Faithfully,
==> picture [156 x 64] intentionally omitted <==
Rajat Kai a Company Secretary and Legal Head
==> picture [63 x 69] intentionally omitted <==
Encl: As above
Regd. Office: Or. L�I P"thl2DS Ltv .. s:,.:Jc E, Sector-18, Rol1i,1i, Nev1• De'�i- 110085, +9I-l l-30258600, Fax: +91-J l-2788-2I34 Corporate Office: Or. Lal Pat'1Labs Ltd., 12th F/c;or. Tc-wer S, SAS Tcwer. M"<fidr:y, S<'cL0I-33, Gurugram- 122 00/, Har;ana +9l-l24-3:Jl6-500, Fax: +91-124-4234-4(;9 E-m: i /· "'pall 1idw • .::-•1alpalh/abs com, Web: .\':."N./aipathiabs ccm. CIN No.: L748', ,OL l 99SPLC065388
"I,_ "'
Conference Call Invitation
==> picture [209 x 72] intentionally omitted <==
Dr. LalPathLabs’ Concall Invitation
Conference Call to share Business Updates Monday, March 30, 2020 at 06:00pm IST
Gurgaon, March 27, 2020:
Dr. Lal PathLabs Ltd. (DLPL) will be hosting a conference call to discuss business updates. DLPL will be represented by (Hony) Brig. Dr. Arvind Lal - Chairman and Managing Director, Dr. Om Prakash Manchanda - Whole-time Director and CEO, Mr. Ved Prakash Goel - CFO. We would also have Mr. Bharath U - CEO (India Business) and Mr. Rajat Kalra - Company Secretary & Head of Investor Relations.
The conference call will be initiated with a brief discussion by the management, following which, there will be an opportunity for participants to get their queries addressed during the call.
Details of the conference call are as follows:
| Time | • 06:00pm IST on Monday, March 30, 2020 |
|---|---|
| Universal Access | • +91 22 6280 1141 • +91 22 7115 8042 |
| Local Access | • +91-7045671221 (Available all over India) |
| • USA – 18667462133 |
|
| Conference dial-in | • UK – 08081011573 |
| International Toll Number | • Singapore – 8001012045 |
| • HongKong – 800964448 |
-ENDS-
Regd. Office: Dr. Lal PathLabs Ltd., Block E, Sector-I8, Rohini, New Delhi – 110085, Tel: +91-11 30258600. Fax: +91-11-2788-2134 Corporate Office: Or. Lal PathLabs Ltd., 12[th] Floor, Tower B, SAS Tower, Medicity, Sector-38, Gurugram - 122001, Haryana, Tel: +91-124-3016-500, Fax: +91-124-4234-468 E-mail: [email protected], Web: www.lalpathlabs.com, CIN: L74899DL 1995PLC065388
About Dr. Lal PathLabs Limited (DLPL)
Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates.
As on March 31, 2019, DLPL’s has 200 clinical labs (including National Reference Lab at Delhi & Regional Reference Lab at Kolkata), 2,569 Patient Service Centers (PSCs) and 6,426 Pick-up Points (PUPs). In FY18 & FY19, DLPL collected and processed approximately 34.7 million samples and 41.8 million samples from approximately 15.2 million and 17.6 million patients, respectively.
Additional information on Dr. Lal PathLabs Limited: Corporate Identification No: L74899DL1995PLC065388 Website: https://www.lalpathlabs.com/
For further information please contact:
Ved Goel / Rajat Kalra Siddharth Rangnekar / Nishid Solanki Dr. Lal PathLabs Limited CDR India E-mail: [email protected] Email: [email protected] [email protected] [email protected]
Regd. Office: Dr. Lal PathLabs Ltd., Block E, Sector-I8, Rohini, New Delhi – 110085, Tel: +91-11 30258600. Fax: +91-11-2788-2134 Corporate Office: Or. Lal PathLabs Ltd., 12[th] Floor, Tower B, SAS Tower, Medicity, Sector-38, Gurugram - 122001, Haryana, Tel: +91-124-3016-500, Fax: +91-124-4234-468 E-mail: [email protected], Web: www.lalpathlabs.com, CIN: L74899DL 1995PLC065388